Profile data is unavailable for this security.
About the company
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
- Revenue in USD (TTM)2.35m
- Net income in USD-28.03m
- Incorporated2018
- Employees102.00
- LocationRenalytix PLCFinsgate, 5-7 Cranwood StreetLONDON EC1V 9EEUnited KingdomGBR
- Phone+44 292 071 0570
- Websitehttps://renalytix.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Femasys Inc | 2.06m | -19.80m | 28.36m | 69.00 | -- | 5.04 | -- | 13.76 | -0.7198 | -0.7198 | 0.07 | 0.0963 | 0.1294 | 0.1973 | 4.34 | 29,876.81 | -124.24 | -63.09 | -214.46 | -74.30 | 63.05 | 66.63 | -960.53 | -961.82 | 0.6131 | -9.72 | 0.5982 | -- | 51.97 | 11.89 | -32.07 | -- | 4.01 | -- |
| PetVivo Holdings Inc | 1.41m | -9.65m | 28.54m | 24.00 | -- | 6.70 | -- | 20.26 | -0.402 | -0.402 | 0.0592 | 0.1269 | 0.3337 | 0.6261 | 10.37 | 58,701.67 | -224.88 | -195.28 | -343.15 | -346.33 | 78.88 | 74.58 | -673.99 | -1,163.49 | 1.45 | -4.23 | 0.00 | -- | 16.91 | 216.08 | 23.33 | -- | 49.21 | -- |
| Wellgistics Health Inc | 34.08m | -77.75m | 28.58m | 31.00 | -- | 4.20 | -- | 0.8386 | -1.32 | -1.32 | 0.6161 | 0.0758 | 0.629 | 3.63 | 17.53 | -- | -143.52 | -- | -365.21 | -- | 7.86 | -- | -228.17 | -- | 0.1628 | -16.42 | 0.7854 | -- | -- | -- | -136.77 | -- | -- | -- |
| Myomo Inc | 41.64m | -12.02m | 29.71m | 184.00 | -- | 2.03 | -- | 0.7136 | -0.2885 | -0.2885 | 1.01 | 0.3805 | 1.65 | 3.96 | 9.23 | 226,321.70 | -47.71 | -55.96 | -70.30 | -77.40 | 66.56 | 69.74 | -28.86 | -52.92 | 2.10 | -- | 0.2148 | -- | 69.17 | 53.36 | 24.10 | -- | 92.10 | -- |
| Vivos Inc | 48.63k | -3.01m | 30.85m | 10.00 | -- | 14.15 | -- | 634.36 | -0.0068 | -0.0068 | 0.0001 | 0.0048 | 0.0275 | -- | 10.03 | -- | -170.12 | -166.49 | -178.25 | -242.01 | -127.33 | 2.81 | -6,191.01 | -11,105.98 | 19.81 | -- | 0.00 | -- | 43.59 | 24.13 | -0.5424 | -- | -- | -- |
| Ekso Bionics Holdings Inc | 14.75m | -10.66m | 31.76m | 61.00 | -- | 2.54 | -- | 2.15 | -5.70 | -5.70 | 7.25 | 3.69 | 0.5799 | 1.36 | 2.27 | 241,786.90 | -41.02 | -41.01 | -60.62 | -52.90 | 53.48 | 52.89 | -70.74 | -97.04 | 1.09 | -- | 0.3055 | -- | -1.94 | 5.19 | 25.45 | -- | -9.22 | -- |
| Vaso Corp | 89.11m | 2.59m | 32.55m | 298.00 | 12.60 | 1.15 | 9.82 | 0.3653 | 0.0147 | 0.0147 | 0.5065 | 0.1605 | 1.13 | 34.02 | 10.28 | 299,030.20 | 3.27 | 7.37 | 5.36 | 14.56 | 60.91 | 59.17 | 2.91 | 5.99 | 1.61 | -- | 0.01 | -- | 7.09 | 2.82 | -80.21 | -- | 3.81 | -- |
| Renalytix PLC (ADR) | 2.35m | -28.03m | 33.10m | 102.00 | -- | -- | -- | 14.07 | -8,201.69 | -8,201.69 | 670.03 | -2,131.80 | 0.1933 | -- | 2.46 | -- | -230.38 | -89.70 | -- | -117.39 | 12.71 | -- | -1,191.75 | -1,669.64 | -- | -7.18 | -- | -- | -32.74 | -- | 26.64 | -- | -79.60 | -- |
| Baird Medical Investment Holdings Ltd | 31.86m | -3.12m | 33.23m | 143.00 | -- | 0.675 | -- | 1.04 | -0.1128 | -0.1128 | 1.22 | 1.34 | 0.4552 | 3.27 | 0.8459 | 222,797.30 | -4.48 | -- | -7.64 | -- | 86.94 | -- | -9.84 | -- | 1.67 | -0.323 | 0.3856 | -- | 17.74 | -- | 18.57 | -- | -- | -- |
| Guided Therapeutics Inc | 178.00k | -2.80m | 33.43m | 4.00 | -- | -- | -- | 187.82 | -0.0386 | -0.0386 | 0.0025 | -0.0675 | 0.1654 | 0.1083 | 44.50 | 44,500.00 | -244.61 | -129.80 | -- | -- | 62.92 | 44.19 | -1,478.65 | -4,184.72 | 0.0334 | -4.13 | -- | -- | -92.86 | -27.93 | 31.07 | -- | -- | -- |
| Modular Medical Inc | 0.00 | -24.22m | 34.33m | 54.00 | -- | 3.08 | -- | -- | -0.5081 | -0.5081 | 0.00 | 0.1434 | 0.00 | -- | -- | 0.00 | -222.79 | -171.42 | -294.38 | -207.14 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.75 | -- | 57.07 | -- |
| RenovoRx Inc | 928.00k | -11.11m | 34.85m | 10.00 | -- | 4.31 | -- | 37.55 | -0.4375 | -0.4375 | 0.0312 | 0.2204 | 0.0874 | -- | -- | 92,800.00 | -104.58 | -121.57 | -126.33 | -166.50 | 67.78 | -- | -1,196.66 | -90,830.23 | 5.68 | -- | 0.00 | -- | -- | -- | 13.86 | -- | -- | -- |
| TELA Bio Inc | 77.06m | -39.00m | 35.02m | 209.00 | -- | 20.73 | -- | 0.4545 | -0.8863 | -0.8863 | 1.75 | 0.0386 | 1.34 | 2.01 | 6.85 | 368,684.20 | -68.06 | -51.29 | -96.57 | -60.70 | 67.23 | 66.26 | -50.61 | -88.02 | 2.62 | -7.25 | 0.9638 | -- | 18.56 | 35.02 | 18.91 | -- | -18.18 | -- |
| Precipio Inc | 22.80m | -1.25m | 35.69m | 54.00 | -- | 2.59 | 147.47 | 1.57 | -0.835 | -0.835 | 14.63 | 7.88 | 1.20 | 18.26 | 15.31 | 422,222.20 | -6.58 | -38.01 | -8.60 | -46.98 | 44.82 | 33.80 | -5.50 | -71.34 | 1.10 | -24.19 | 0.074 | -- | 21.95 | 42.74 | 26.70 | -- | 32.31 | -- |
| Neuroone Medical Technologies Corp | 12.10m | -3.61m | 37.07m | 18.00 | -- | 5.20 | -- | 3.06 | -0.0784 | -0.0784 | 0.3012 | 0.1414 | 1.50 | 1.63 | 16.79 | 672,094.40 | -44.63 | -113.64 | -61.95 | -152.08 | 67.30 | 60.94 | -29.80 | -223.44 | 3.47 | -- | 0.1519 | -- | 250.35 | 44.41 | 70.73 | -- | -7.76 | -- |
| Icecure Medical Ltd | 2.98m | -15.29m | 38.01m | 64.00 | -- | 4.08 | -- | 12.78 | -0.2586 | -0.2586 | 0.0501 | 0.1349 | 0.196 | 0.8235 | 24.39 | 46,484.38 | -100.74 | -61.14 | -155.92 | -77.11 | 35.06 | 50.17 | -513.95 | -343.95 | 1.90 | -- | 0.00 | -- | 1.92 | 15.35 | -4.55 | -- | -6.51 | -- |
Data as of Feb 06 2026. Currency figures normalised to Renalytix PLC's reporting currency: US Dollar USD
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Ironwood Investment Counsel LLCas of 30 Sep 2025 | 400.00 | 0.01% |
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
